PAPER Azargoonjahromi A, Alzheimer’s Disease Neuroimaging Initiative

Plasma tryptophan levels are linked to hippocampal integrity and cognitive function in individuals with mild cognitive impairment.

Brain Imaging Behav. 2025 Mar 4; Epub 2025 Mar 4 PubMed.

PAPER Kumar H, Datusalia AK, Kumar A, Khatik GL

Network pharmacology exploring the mechanistic role of indirubin phytoconstituent from Indigo naturalis targeting GSK-3β in Alzheimer's disease.

J Biomol Struct Dyn. 2025 Mar 4;:1-14. Epub 2025 Mar 4 PubMed.

PAPER Maazouzi M, Rasheed M, Mbarek L, Wang X, Liang J, Ma H, Chen Z, Deng Y

Exploring Non-Coding RNA Regulation of the Blood-Brain Barrier in Neurodegenerative Diseases: A Systematic Review.

J Neurochem. 2025 Mar;169(3):e70031. PubMed.

PAPER Arendt P, Römpler K, Brix B, Borchardt-Lohölter V, Busse M, Busse S

Corrigendum: Differentiation of Alzheimer's disease from other neurodegenerative disorders using chemiluminescence immunoassays measuring cerebrospinal fluid biomarkers.

Front Dement. 2025;4:1568275. Epub 2025 Feb 17 PubMed. Corrected paper.

PAPER Shimokawa H, Akishita M, Ihara M, Teramukai S, Ishiki A, Nagai Y, Fukushima M

Pivotal trial of low-intensity pulsed ultrasound therapy for early Alzheimer's disease: Rationale and design.

J Alzheimers Dis Rep. 2025;9:25424823241312108. Epub 2025 Jan 13 PubMed.

PAPER Simpson AJ, Wyman-Chick KA, Daniel MS

Neuropsychological and clinical indicators of Lewy body and Alzheimer's pathology.

J Alzheimers Dis Rep. 2025;9:25424823241304386. Epub 2025 Jan 13 PubMed.

PAPER Dos Santos Ono RM, Dos Santos Moreira NC, Carvalho I, Passos GA, Sakamoto-Hojo ET

Novel donepezil-tacrine hybrid (TAHB3) induces neurodifferentiation, neuroprotective effects, and activates the PI3K/AKT pathway on PC12 cells.

J Alzheimers Dis Rep. 2025;9:25424823241309268. Epub 2025 Jan 13 PubMed.

PAPER Ott FW, Sichler ME, Bouter C, Enayati M, Wiltfang J, Bayer TA, Beindorff N, Löw MJ, Bouter Y

Chronic exposure to a synthetic cannabinoid improves cognition and increases locomotor activity in Tg4-42 Alzheimer's disease mice.

J Alzheimers Dis Rep. 2025;9:25424823241306770. Epub 2025 Feb 27 PubMed.

PAPER Cui L, Wan Y, Lu Y, Meng M, Zhang N

Sleep disturbances and their correlation with memory impairment in patients with Alzheimer's disease and amnestic mild cognitive impairment.

J Alzheimers Dis Rep. 2025;9:25424823241309063. Epub 2025 Jan 13 PubMed.

PAPER Mohamed Amine J, Mourad M, Alzheimer's Disease Neuroimaging Initiative (ADNI)

Alzheimer's disease classification by supervised and intelligent techniques.

J Alzheimers Dis Rep. 2025;9:25424823241311838. Epub 2025 Jan 13 PubMed.

PAPER Wang L, Wang X, Hou L, Liu Y, Liu J, Zhang D, Yao S, Zheng D

Protective effect of chlorogenic acid on cognitive impairment in rats with early Alzheimer's disease via Wnt signaling pathway.

J Alzheimers Dis Rep. 2025;9:25424823251315848. Epub 2025 Feb 9 PubMed.

PAPER Al-Abbas NS, Shaer NA

Gut microbiome synthesizes important core metabolites to prevent cognitive decline and mitigate onset and progression of Alzheimer's disease.

J Alzheimers Dis Rep. 2024;8(1):1705-1721. Epub 2024 Dec 23 PubMed.

PAPER Xu J, Liu B, Shang G, Liu S, Feng Z, Yang H, Liu D, Chang Q, Chen Y, Yu X, Mao Z

Deep brain stimulation of the nucleus basalis of Meynert in severe Alzheimer's disease.

J Alzheimers Dis Rep. 2024;8(1):1573-1586. Epub 2024 Nov 24 PubMed.

PAPER Iga JI, Yoshino Y, Ozaki T, Tachibana A, Kumon H, Funahashi Y, Mori H, Ueno M, Ozaki Y, Yamazaki K, Ochi S, Yamashita M, Ueno SI

Blood RNA transcripts show changes in inflammation and lipid metabolism in Alzheimer's disease and mitochondrial function in mild cognitive impairment.

J Alzheimers Dis Rep. 2024;8(1):1690-1703. Epub 2024 Dec 23 PubMed.

PAPER Tripathi S, Kaushik M, Dwivedi R, Tiwari P, Tripathi M, Dada R

The effect of probiotics on select cognitive domains in mild cognitive impairment and Alzheimer's disease: A systematic review and meta-analysis.

J Alzheimers Dis Rep. 2024;8(1):1422-1433. Epub 2024 Oct 18 PubMed.